Dr
Zeinab
Mohamed
Dr
Zeinab
Mohamed
R&D lead scientist
VSVRI
Biography
My name is Zeinab Mohamed Ali, and I am proud to be from Egypt. I graduated from the Faculty of Veterinary Medicine at Cairo University in 2005, which marked the beginning of my journey in veterinary science.
After completing my degree, I joined the Veterinary Serum and Vaccine Research Institute (VSVRI) as an assistant researcher. This role allowed me to dive deeper into my passion for veterinary virology, which ultimately led me to pursue further studies. I earned my Master’s degree in Veterinary Virology in 2010, followed by a PhD in the same field in 2017.
In 2024, I reached an exciting milestone in my career when I became the Lead Scientist in Research and Development for veterinary vaccines at Evpharma Animal Health. In this role, I am dedicated to advancing the field of veterinary medicine and improving animal health through innovative vaccine solutions.
Throughout my journey, I have remained committed to research and development, and I am passionate about making a positive impact on animal health and welfare. Research interests
As a lead scientist specializing in vaccine development, my primary research interests lie in the innovative design and production of egg-based and tissue culture vaccines. My work focuses on enhancing vaccine efficacy and safety through advanced methodologies that cater to diverse veterinary applications.
I am particularly passionate about exploring the intricacies of vaccine formulation and the optimization of production processes. This includes collaborating with various vaccine manufacturers to streamline development pipelines and improve overall vaccine quality. My aim is to contribute to the advancement of veterinary medicine by ensuring that our vaccines not only meet regulatory standards but also effectively safeguard animal health.
In addition to my technical expertise, I am committed to fostering interdisciplinary collaborations that drive forward-thinking solutions in vaccine research. I believe that by integrating insights from virology, immunology, and biotechnology, we can pave the way for groundbreaking innovations in vaccine development.
Projects you're working on
As a lead scientist specializing in vaccine development, I have been deeply involved in several innovative projects focused on egg-based and tissue culture vaccines. One of my primary areas of research has been the development of inactivated vaccines targeting Newcastle Disease Virus (NDV) genotypes 2 and 7.
My work includes the formulation of combined vaccines that integrate NDV with other significant avian pathogens, such as H9N2, H5N1, and H5N8. Notably, I have contributed to the development of a combined vaccine that effectively targets H5N1, H5N8, and NDV genotype 7.
These projects aim to enhance the efficacy and safety of vaccines, ensuring better protection for poultry against these prevalent viral threats. By leveraging my expertise in veterinary virology, I strive to contribute to the advancement of vaccine technology, ultimately improving animal health and agricultural stability.
Discipline
Bacteriology Bio-manufacturing Bioinformatics Cellular biology Challenge model development Challenge study design Clinical trials – efficacy Clinical trials – safety Commercialisation Deployment Economics Epidemiology Ethics Formulation technology Immunology – B-cells Immunology – T-cells Immunology – innate Molecular biology Pharmacovigilance Protein biology QC test development Quality assurance Registration Regulation Safety evaluation Social sciences Statistics Structural biology Systems biology Virology Host species
Buffalo Cats Cattle Dogs Horses Poultry Small ruminants Zoonoses Pathogen
Viruses Viruses›Adenovirus Viruses›African horse sickness virus Viruses›Avian polyomavirus Viruses›Bluetongue virus Viruses›Bovine ephemeral fever virus Viruses›Bovine viral diarrhoea Viruses›Chicken anaemia virus Viruses›Coronavirus Viruses›Ebolaviruses/filoviruses Viruses›Feline leukaemia virus Viruses›Foot-and-mouth disease virus Viruses›Herpesvirus Viruses›Infectious bursal disease virus Viruses›Infectious pancreatic necrosis virus Viruses›Influenza virus Viruses›Mareks disease virus Viruses›Newcastle disease virus Viruses›Parainfluenza virus Viruses›Paramyxoviruses Viruses›Parvovirus Viruses›Peste des petits ruminants virus Viruses›Porcine reproductive and respiratory syndrome virus Viruses›Poxviruses Viruses›Rabies virus Viruses›Respiratory syncytial virus Viruses›Retroviruses Viruses›Rift Valley fever virus Viruses›Rotavirus Stage of vaccine development
Adjuvants Antigen discovery and immunogen design Clinical trials Commercialisation Correlates of protection – immunomonitoring Deployment Field trials Marketing Pre-clinical trials Vaccine delivery